MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

19 Jul 2024 Evaluate
The sales is pegged at Rs. 1667.00 millions for the June 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 2174.00 millions during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -102.00 millions as compared to Net Profit of Rs. 19.00 millions of corresponding quarter ended June 2023OP of the company witnessed a marginal growth to 207.00 millions from 201.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1667.00 2174.00 -23.32 1667.00 2174.00 -23.32 7847.00 8101.00 -3.14
Other Income 195.00 159.00 22.64 195.00 159.00 22.64 1034.00 1379.00 -25.02
PBIDT 207.00 201.00 2.99 207.00 201.00 2.99 1199.00 1410.00 -14.96
Interest 76.00 64.00 18.75 76.00 64.00 18.75 299.00 185.00 61.62
PBDT 19.00 137.00 -86.13 19.00 137.00 -86.13 900.00 1225.00 -26.53
Depreciation 131.00 114.00 14.91 131.00 114.00 14.91 483.00 432.00 11.81
PBT -112.00 23.00 -586.96 -112.00 23.00 -586.96 417.00 793.00 -47.41
TAX -10.00 4.00 -350.00 -10.00 4.00 -350.00 101.00 294.00 -65.65
Deferred Tax -10.00 0.00 0.00 -10.00 0.00 0.00 33.00 156.00 -78.85
PAT -102.00 19.00 -636.84 -102.00 19.00 -636.84 316.00 499.00 -36.67
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.00 159.00 0.00
PBIDTM(%) 12.42 9.25 34.31 12.42 9.25 34.31 15.28 17.41 -12.21
Peers
Company Name CMP
Sun Pharma. Inds. 1878.15
Dr. Reddys Labs. 1205.95
Cipla 1391.40
Lupin 2118.00
Zydus Lifesciences 1159.05
View more..